{"version":"1.0","type":"rich","provider_name":"techandbusiness.org","provider_url":"https://techandbusiness.org","title":"Taysha says Rett gene therapy manufacturing campaign met commercial criteria","author_name":"techandbusiness.org · Tech & Business","thumbnail_url":"https://ml.globenewswire.com/media/a88cd5f5-0b05-416c-a56b-e4130c10cfca/small/new-taysha-inline-fullcolor-rgb-12in-300ppi-jpg.jpg","width":600,"height":400,"html":"<blockquote class=\"tb-newswire-embed\" style=\"max-width:600px;border-left:3px solid #22d3ee;padding:12px 16px;margin:0;font-family:-apple-system,system-ui,sans-serif;background:#09090b;border-radius:0 8px 8px 0;\">\n      <p style=\"margin:0 0 8px;font-size:10px;font-weight:600;letter-spacing:0.1em;color:#71717a;\">techandbusiness.org · Tech & Business</p>\n      <p style=\"margin:0 0 8px;font-size:18px;font-weight:700;line-height:1.3;color:#fff;\"><a href=\"https://techandbusiness.org/newswire/dL8Bq5Cvul5mo1Q9hvSeOl\" style=\"color:#fff;text-decoration:none;\">Taysha says Rett gene therapy manufacturing campaign met commercial criteria</a></p>\n      <p style=\"margin:0;font-size:14px;color:#a1a1aa;line-height:1.5;\">Taysha Gene Therapies said it completed a manufacturing qualification campaign for TSHA-102, its investigational Rett syndrome gene therapy, meeting predefined product specifications and criteria comparing commercial product with clinical material....</p>\n    </blockquote>"}